These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19876579)

  • 1. [Use of the prognosis markers in the treatment for the invasive cervical carcinoma].
    Silva Filho AL
    Rev Bras Ginecol Obstet; 2009 Sep; 31(9):468-73. PubMed ID: 19876579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microinvasive carcinoma of the uterine cervix. Risk factors and therapeutic options].
    Gentili C; Calcinai A; Cristofani R
    Minerva Ginecol; 2000 Mar; 52(3):83-92. PubMed ID: 10905081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of pathological characteristics of invasive margins in early-stage squamous cell carcinomas of the uterine cervix.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Lekawanvijit S; Siriaunkgul S
    Asian Pac J Cancer Prev; 2013; 14(9):5165-9. PubMed ID: 24175794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of selected prognostic factors on the results of combined treatment of invasive carcinoma of the cervix on stage IB and stage IIA].
    Panek G; Kamińska G; Zieliński J
    Ginekol Pol; 1999 Jul; 70(7):484-9. PubMed ID: 10895293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical hysterectomy for stage IIB cervical cancer: a review.
    Suprasert P; Srisomboon J; Kasamatsu T
    Int J Gynecol Cancer; 2005; 15(6):995-1001. PubMed ID: 16343175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors in stage Ia-IIb invasive cervix cancer after radical hysterectomy with special reference to stroma reaction].
    Reinthaller A; Tatra G; Breitenecker G; Janisch H
    Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):809-13. PubMed ID: 1761169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix.
    Gauthier P; Gore I; Shingleton HM; Soong SJ; Orr JW; Hatch KD
    Obstet Gynecol; 1985 Oct; 66(4):569-74. PubMed ID: 4047545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
    Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
    Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
    Yan M; Zhang YN; He JH; Sun JR; Sun XM
    Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
    Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
    Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
    Bean LM; Ward KK; Plaxe SC; McHale MT
    Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
    Atasii T; Aksu MF; Cetinkaya MB
    Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis.
    Zhang Q; Xiong Y; Ye J; Zhang L; Li L
    PLoS One; 2018; 13(4):e0192784. PubMed ID: 29641578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.